miR-17-92 is also overexpressed in MLL (mixed lineage leukemia)-rearranged acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) [25], and in CD34+ chronic myeloid leukemia (CML) [26]. This evidence concerns the gene KMT2A and acute myeloid leukemia.